Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Etanercept in Suppression of the Systemic Inflammatory Response in Hemodialysis Patients

NCT00293202 is registered in ClinicalTrials.gov with Kaysen, George A., M.D., Ph.D. as lead sponsor.

NCT NCT00293202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00293202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Etanercept in Suppression of the Systemic Inflammatory Response in Hemodialysis Patients
Lead sponsor
Kaysen, George A., M.D., Ph.D.
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2005
Completion date
June 30, 2010
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease